DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, and INTEGRIN ALPHA SUBUNIT Protein and nucleic acid molecules and uses thereof
    9.
    发明申请
    DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, and INTEGRIN ALPHA SUBUNIT Protein and nucleic acid molecules and uses thereof 有权
    DELTA3,FTHMA-070,TANGO85,TANGO77,SPOIL,NEOKINE,TANGO129和INTEGRIN ALPHA SUBUNIT蛋白质和核酸分子及其用途

    公开(公告)号:US20090286956A1

    公开(公告)日:2009-11-19

    申请号:US11974478

    申请日:2007-10-12

    IPC分类号: C07K14/705

    摘要: The invention provides novel Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 polypeptides, proteins, and nucleic acid molecules. In addition to isolated, full-length Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 proteins, the invention further provides isolated Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 fusion proteins, antigenic peptides and anti-Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 antibodies. The invention also provides Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 or A259 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.

    摘要翻译: 本发明提供新颖的Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259多肽,蛋白质和核酸分子。 除了分离的全长Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259蛋白外,本发明还提供了分离的Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259融合 蛋白质,抗原肽和抗Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259抗体。 本发明还提供了Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259核酸分子,含有本发明的核酸分子的重组表达载体,已经引入表达载体的宿主细胞, 已经引入或破坏了Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129或A259基因的人类转基因动物。 还提供利用本发明组合物的诊断,筛选和治疗方法。

    DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
    10.
    发明申请
    DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof 审中-公开
    DELTA3,FTHMA-070,TANGO85,TANGO77,SPOIL,NEOKINE,TANGO129和整合素α亚基蛋白和核酸分子及其用途

    公开(公告)号:US20080220495A1

    公开(公告)日:2008-09-11

    申请号:US11974465

    申请日:2007-10-12

    IPC分类号: C12N11/00 C07K16/00 C07K17/00

    摘要: The invention provides novel Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 polypeptides, proteins, and nucleic acid molecules. In addition to isolated, full-length Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 proteins, the invention further provides isolated Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 fusion proteins, antigenic peptides and anti-Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 antibodies. The invention also provides Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 and A259 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a Delta3, FTHMA-070, Tango85, Tango77, SPOIL, NEOKINE, Tango129 or A259 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.

    摘要翻译: 本发明提供新颖的Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259多肽,蛋白质和核酸分子。 除了分离的全长Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259蛋白外,本发明还提供了分离的Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259融合 蛋白质,抗原肽和抗Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259抗体。 本发明还提供了Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129和A259核酸分子,含有本发明的核酸分子的重组表达载体,已经引入了表达载体的宿主细胞, 已经引入或破坏了Delta3,FTHMA-070,Tango85,Tango77,SPOIL,NEOKINE,Tango129或A259基因的人类转基因动物。 还提供利用本发明组合物的诊断,筛选和治疗方法。